Oncolytic viruses as a promising therapeutic strategy for hematological malignancies
Open Access
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 139, 111573
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-βCancer Gene Therapy, 2012
- Myxoma Virus Sensitizes Cancer Cells to Gemcitabine and Is an Effective Oncolytic Virotherapeutic in Models of Disseminated Pancreatic CancerMolecular Therapy, 2012
- Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma ModelHuman Gene Therapy, 2011
- A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant GliomaMolecular Pharmaceutics, 2011
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virusCytokine & Growth Factor Reviews, 2010
- Directing systemic oncolytic viral delivery to tumors via carrier cells☆Cytokine & Growth Factor Reviews, 2010
- Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for GlioblastomaMolecular Therapy, 2010
- Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery ApproachMolecular Therapy, 2010
- Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer TherapyMolecular Therapy, 2009
- Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoGene Therapy, 2008